根据提交给美国证券交易委员会（SEC）的文件，艾伯维公司在2026年第二季度业绩中计入了高达2.91亿美元的“购买无形资产研发”（IPR&D）费用。此项一次性支出对公司的财务指标产生了显著影响，具体表现为：按美国通用会计准则（GAAP）计算的稀释每股收益（EPS）以及调整后的稀释每股收益均因此减少了0.17美元。
购买IPR&D费用通常与收购交易相关，指为获取尚处研发阶段、尚未商业化的无形资产而支付的款项。这笔巨额费用的计入，直接拉低了艾伯维当季的盈利表现。尽管这是一项非现金、非经常性项目，但它清晰地反映了公司在通过外部并购强化其研发管线方面所进行的积极投资。投资者在评估公司核心运营业绩时，需关注此类调整项的影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.